DNA adducts: Biological markers of exposure and potential applications to risk assessment

Mutation Research - Reviews in Genetic Toxicology

Volumn 365, Issue 1-3, 1996, Pages 129-146

  La, David K ^a   Swenberg, James A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

biologically based risk assessment; biomarkers; dose reponse; molecular dosimetry

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN;

ANIMAL EXPERIMENT; BIOLOGICAL MONITORING; CANCER RISK; CARCINOGENESIS; DNA ADDUCT; DNA REPAIR; DOSE RESPONSE; DOSIMETRY; HUMAN; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; RISK ASSESSMENT;

ANIMALIA;

EID: 0030250912     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1110(96)90017-2     Document Type: Article

References (123)

1. 4-ethenocytosine , DNA reaction products of vinyl chloride metabolites, during in vitro DNA synthesis. Nucleic Acids Res. 9:1981;375-387.
2. Barbin A., Laib R.J., Bartsch H. Lack of miscoding properties of 7-(2-oxoethyl)guanine, the major vinyl chloride-DNA adduct. Cancer Res. 45:1985;2440-2444.
3. Bartsch H., Barbin A., Marion M.J., Nair J., Guichard Y. Formation, detection, and role in carcinogenesis of ethenobases in DNA. Drug Metab. Rev. 26:1994;349-371.
4. Basu A.K., Essigmann J.M. Site-specifically alkylated oligodeoxynucleotides: probes for mutagenesis, DNA repair and the structural effects of DNA damage. Mutation Res. 233:1990;189-201.
5. 4-ethenocytosine , and 4-amino-5-(imidazol-2-yl)imidazole, Biochemistry. 32:1993;12793-12801.
6. Belinsky S.A., Devereux T.R., Maronpot R.R., Stoner G.D., Anderson M.W. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res. 49:1989;5305-5311.
7. Belinsky S.A., Devereux T.R., Anderson M.W. Role of DNA methylation in the activation of protooncogenes and the induction of pulmonary neoplasia by nitrosamines. Mutation Res. 233:1990a;105-116.
8. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 50:1990b;3772-3780.
9. Benford D.J., Price S.C., Lawrence J.N., Grasso P., Bremmer J.N. Investigations of the genotoxicity and cell proliferative activity of dichlorvos in mouse forestomach. Toxicology. 92:1994;203-215.
10. Beranek D.T. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutation Res. 231:1990;11-30.
11. Bianchini F., Wild C.P. Comparison of 7-medG formation in white blood cells, liver and target organs in rats treated with methylating carcinogens. Carcinogenesis. 15:1994;1137-1141.
12. Bogdanffy M.S., Makovec G.T., Frame S.R. Inhalation oncogenicity bioassay in rats and mice with vinyl fluoride. Fundam. Appl. Toxicol. 26:1995;223-238.
13. Bois F.Y., Krowech G., Zeise L. Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl. Risk Anal. 15:1995;205-213.
14. Boles T.C., Hogan M.E. High-resolution mapping of carcinogen binding sites on DNA. Biochemistry. 25:1986;3039-3043.
15. Butterworth B.E., Popp J.A., Conolly R.B., Goldsworthy T.L. Chemically induced cell proliferation in carcinogenesis. Vainio H., Magee P.N., McGregor D.B., McMichael A.J. Mechanisms of Carcinogenesis in Risk Identification. IARC Scientific Publications No. 116. 1992;279-305 IARC, Lyon.
16. 3H]formaldehyde. Toxicol. Appl. Pharmacol. 76:1984;26-44.
17. Cerutti P., Hussain P., Pourzand C., Aguilar F. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene. Cancer Res. 54:(Suppl.):1994;1934s-1938s.
18. Chaudhary A.K., Nokubo M., Reddy G.R., Yeola S.N., Morrow J.D., Blair I.A., Marnett L.J. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science. 265:1994;1580-1582.
19. Chaudhary A.K., Nokubo M., Oglesby T.D., Marnett L.J., Blair I.A. Characterization of endogenous DNA adducts by liquid chromatography/electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 30:1995;1157-1166.
20. Chen B., Liu L., Castonguay A., Maronpot R.R., anderson M.W., You M. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosoamino)-1-(pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis. 14:1993;1603-1608.
21. 2,3-ethenoguanine produces G → A transitions in Escherichia coli. Proc. Natl. Acad. Sci. USA. 88:1991;8878-9974.
22. Cohen S.M., Ellwein L.B. Cell proliferation in carcinogenesis. Science. 249:1990a;1007-1011.
23. Cohen S.M., Ellwein L.B. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study. Toxicol. Appl. Pharmacol. 104:1990b;79-93.
24. Cunningham M.L. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutation Res. 1996;. in press.
25. Dolan M.E., Oplinger M., Pegg A.E. Sequence specificity of guanine alkylation and repair. Carcinogenesis. 9:1988;2139-2143.
26. Doll R. Effects of exposure to vinyl chloride: an assessment of the evidence. Scand. J. Work Environ. Health. 14:1988;61-78.
27. Dragan Y.P., Hully J.R., Nakamura J., Mass M.J., Swenberg J.A., Pitot H.C. Biochemical events during initiation of rat hepatocarcinogenesis. Carcinogenesis. 15:1994;1451-1458.
28. Dybing E., Huitfield H.S. Species differences in carcinogen metabolism and interspecies extrapolation. Vainio H., Magee P.N., McGregor D.B., McMichael A.J. Mechanisms of Carcinogenesis in Risk Identification. IARC Scientific Publications No. 116. 1992;501-522 IARC, Lyon.
29. Eaton D.L., Gallagher E.P. Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34:1994;135-172.
30. 1 in vitro. Proc. Natl. Acad. Sci. USA. 74:1977;1870-1874.
31. Farmer P.B., Bailey E., Naylor S., Anderson D., Brooks A., Cushnir J., Lamb J.H., Sepai O., Tang Y.S. Identification of endogenous electrophiles by means of mass spectrometric determination of protein and DNA adducts. Environ. Health Perspect. 99:1993;19-24.
32. Fedtke N., Swenberg J.A. Quantitative analysis of DNA adducts: the potential for mass spectrometric techniques. Groopman J.D., Skipper P.L. Molecular Dosimetry and Human Cancer. 1991;171-188 CRC Press, Boca Raton.
33. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis. 11:1990;1447-1450.
34. Friedberg E.C., Walker G.C., Siede W. DNA Repair and Mutagenesis. 1995;ASM Press, Washington, DC.
35. Ghanayem B.I., Maronpot R.R., Matthews H.B. Association of chemically induced forestomach cell proliferation and carcinogenesis. Cancer Lett. 32:1986;271-278.
36. Goth R., Rajewsky M.F. Persistence of O6-ethylguanine in rat brain DNA: correlation with nervous system specific carcinogenesis by ethylnitrosourea. Proc. Natl. Acad. Sci. USA. 71:1974;639-653.
37. Guengerich F.P. Mechanisms of formation of DNA adducts from ethylene dihalides, vinyl halides and arylamines. Drug Metab. Rev. 26:1994;47-66.
38. Harris C.C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. 51:(Suppl.):1991;5023s-5044s.
39. Haseman J.K. Issues in carcinogenicity testing: dose selection. Fundam. Appl. Toxicol. 5:1985;66-78.
40. Heflich R.H., Neft R.E. Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites. Mutation Res. 318:1994;73-174.
41. Hollstein M., Marion M.J., Lehman T., Welsh J., Harris C.C., Martel-Planche G., Kusters I., Montesano R. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis. 15:1994;1-3.
42. 7 position. Proc. Natl. Acad. Sci. USA. 89:1992;8278-8282.
43. Husgafvel-Pursiainen K., Ridanpaa M., Anttila S., Vainio H. p53 and ras gene mutations in lung cancer: implications for smoking and occupational exposures. J. Occup. Environ. Med. 37:1995;69-76.
44. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Vol. 19:1979;377-438 IARC, Lyon.
45. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Vol. 60:1994;45-159 IARC, Lyon.
46. Jerina D.M., Chadha A., Cheh A.M., Schurdak M.E., Wood A.W., Sayer J.M. Covalent binding of bay-region diol epoxides to nucleic acids. Adv. Exp. Med. Biol. 283:1991;533-553.
47. Jernstrom B., Graslund A. Covalent binding of benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxides to DNA: molecular structures, induced mutations and biological consequences. Biophys. Chem. 49:1994;185-199.
48. Jorgenson T.A., Meierhenry E.F., Rushbrook C.J., Bull R.J., Robinson M. Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 5:1985;760-769.
49. Kerns W.D., Pavkov K.L., Donofrio D.J., Connell M.M., Mitchell R.I., Gralla E.J., Swenberg J.A. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res. 43:1983;4382-4392.
50. La D.K., Schoonhoven R., Ito N., Swenberg J.A. Exposure-related differences in DNA adduct formation and cellular proliferation by 1,2,3-trichloropropane. Toxicologist. 15:1995;153.
51. Lawley P.D. Some chemical aspects of dose-response relationships in alkylation mutagenesis. Mutation Res. 23:1974;283-295.
52. Lawley P.D. Carcinogenesis by alkylating agents. Searle C.E. Chemical Carcinogenesis. Vol. 1:1984;325-484 ACS Monograph 182, American Chemical Society, Washington, DC.
53. Leach F.S., Polyak K., Burrell M., Johnson K.A., Hill D., Dunlop M.C., Wyllie A.H., Peltomaki P., de la Chapelle A., Hamilton S.R., Kinzler K.W., Vogelstein B. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res. 56:1996;235-240.
54. Lehman T.A., Greenblatt M., Bennett W.P., Harris C.C. Mutational spectrum of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Drug Metab. Rev. 26:1994;221-235.
55. 6-methylguanine in DNA of rat hepatocytes and non-parenchymal cells. Nature. 288:1980;185-187.
56. Loechler E.L. How are potent bulky carcinogens able to induce such a diverse array of mutations? Mol. Carcinog. 13:1995;213-219.
57. Marion M.J., Froment O., Trepo C. Activation of Ki-ras gene by point mutation in human liver angiocarcinoma associated with vinyl chloride exposure. Mol. Carcinog. 4:1991;450-454.
58. Marnett L.J., Burcham P.C. Endogenous DNA adducts: potential and paradox. Chem. Res. Toxicol. 6:1993;771-785.
59. Miller E.C., Miller J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer. 47:1981;2327-2345.
60. Misra R.R., Kim A., Scheller N., Holt S., Swenberg J.A. Endogenous production of etheno adducts in mammalian DNA. Proc. Am. Assoc. Cancer Res. 35:1994;96.
61. 2,3-ethenoguanine in human and rat liver DNA using high resolution mass spectrometry. Proc. Am. Assoc. Cancer Res. 36:1995;142.
62. Modrich P. Mismatch repair, genetic stability and tumour avoidance. Phil. Trans. R. Soc. Lond. B. 347:1995;89-95.
63. Monro A. What is an appropriate measure of exposure when testing drugs for carcinogenicity in rodents? Toxicol. Appl. Pharmacol. 112:1992;171-181.
64. Monticello T.M., Miller F.J., Morgan K.T. Regional increases in rat nasal epithelial cell proliferation following acute and subchronic inhalation of formaldehyde. Toxicol. Appl. Pharmacol. 111:1991;409-421.
65. Monticello T.M., Swenberg J.A., Gross E.A., Leininger J.R., Kimbell J.S., Seilkop S., Starr T.B., Gibson J.E., Morgan K.T. Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. Cancer Res. 1996;. in press.
66. 2,3-ethenoguanine studied in an Escherichia coli DNA-dependent RNA polymerase in vitro system and possible role of this adduct in vinyl chloride-induced mutagenesis. Mutagenesis. 6:1991;385-390.
67. 32P-postlabelling. Carcinogenesis. 16:1995;613-617.
68. 2-ethylthymidine in liver DNA of rats continuously exposed to diethylnitrosamine. Proc. Am. Assoc. Cancer Res. 33:1992;148.
69. National Cancer Institute (NCI). Carcinogenesis Bioassay of Chloroform. 1976;National Cancer Institute, Bethesda, MD.
70. National Toxicology Program (NTP). Bioassay of Dibromochloropropane for Possible Carcinogenicity (CAS No. 1836-75-5), NTP TR 28. 1978a;National Toxicology Program, Research Triangle Park, NC.
71. National Toxicology Program (NTP). Bioassay of 1,2-Dibromoethane for Possible Carcinogenicity (CAS No. 106-93-4), NTP TR 86. 1978b;National Toxicology Program, Research Triangle Park, NC.
72. National Toxicology Program (NTP). Bioassay of 1,2-Dibromo-3-chloropropane (CAS No. 96-12-8) in F344 Rats and B6C3F1 Mice (Inhalation Study), NTP TR 206. 1982a;National Toxicology Program, Research Triangle Park, NC.
73. National Toxicology Program (NTP). Bioassay of 1,2-Dibromoethane (CAS No. 106-93-4) in F344 Rats and B6C3F1 Mice (Inhalation Study), NTP TR 210. 1982b;National Toxicology Program, Research Triangle Park, NC.
74. National Toxicology Program (NTP). Bioassay of Ethyl Acrylate (CAS No. 140-88-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies), NTP TR 259. 1986;National Toxicology Program, Research Triangle Park, NC.
75. Nesnow S., Ross J., Nelson G., Holden K., Erexson G., Kligerman A., Gupta R.C. Quantitative and temporal relationships between DNA adduct formation in target and surrogate tissues: implications for biomonitoring. Environ. Health Perspect. 101:(Suppl. 3):1993;37-42.
76. Olin S., Farland W., Park C., Rhomberg L., Scheuplein R., Starr T., Wilson J. Low-Dose Extrapolation of Cancer Risks. Issues and Perspectives. 1995;7-43 ILSI Press, Washington, DC.
77. Osborne M.R. Sequence specificity in the reaction of benzopyrene diol epoxide with DNA. Chem. Biol. Interact. 75:1990;131-140.
78. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50:1990;6119-6129.
79. 6-methylguanine from deoxyribonucleic acid in rat liver and kidney after small doses of dimethylnitrosamine. Biochem. J. 173:1978;739-748.
80. Perantoni A.O., Rice J.M., Reed C.D., Watatani M., Wenk M.L. Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc. Natl. Acad. Sci. USA. 84:1987;6317-6321.
81. Poirier M.C. Human exposure monitoring, dosimetry and cancer risk assessment: the use of antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA. Drug Metab. Rev. 26:1994;87-109.
82. Poirier M.C., Beland F.A. DNA adduct measurement and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. Chem. Res. Toxicol. 5:1992;749-755.
83. Poirier M.C., Fullerton N.F., Kinouchi T., Smith B.A., Beland F.A. Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene. Carcinogenesis. 12:1991;895-900.
84. Poulsen H.E., Loft S., Wassermann K. Cancer risk related to genetic polymorphisms in carcinogen metabolism and DNA repair. Pharmacol. Toxicol. 72:(Suppl. 1):1993;93-103.
85. Preston-Martin S., Pike M.C., Ross R.K., Jones P.A., Henderson B.E. Increased cell division as a cause of human cancer. Cancer Res. 50:1990;7415-7421.
86. Pullman B., Pullman A. Nucleophilicity of DNA: relation to chemical carcinogenesis. Pullman B., Ts'O P.O., Gelboin H. Carcinogenesis: Fundamental Mechanisms and Environmental Effects. 1980;55-66 D. Reidel, Dordrecht.
87. Qian G.S., Ross R.K., Yu M.C., Yuan J.M., Gao Y.T., Henderson B.E., Wogan G.N., Groopman J.D. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3:1994;3-10.
88. 32P-Postlabeling methods for DNA adduct detection: overview and critical evaluation. Drug Metab. Rev. 26:1994;67-85.
89. Richardson F.C., Richardson K.K. Sequence-dependent formation of alkyl DNA adducts: a review of methods, results and biological correlates. Mutation Res. 233:1990;127-138.
90. 4-alkylthlymidine following exposure to methylating and ethylating hepatocarcinogens. Carcinogenesis. 6:1985;625-629.
91. Rill R.L., Marsch G.A. Sequence preferences of covalent DNA binding by anti-(+)- and anti-(-)-benzo[a]pyrene diol epoxides. Biochemistry. 29:1990;6050-6058.
92. Rodriguez H., Loechler E.L. Mutagenesis by the (+)-anti-diol epoxide of benzo[a]pyrene : what controls mutagenic specificity? Biochemistry. 32:1993;1759-1769.
93. Rodriguez H., Loechler E.L. Are base substitution and frameshift mutagenesis pathways interrelated? An analysis based upon studies of the frequencies and specificities of mutations induced by the (+)-anti diol epoxide of benzo[a]pyrene . Mutation Res. 326:1995;29-37.
94. Ross R.K., Yuan J.M., Yu M.C., Wogan G.N., Qian G.S., Tu J.T., Groopman J.D., Gao Y.T., Henderson B.E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 339:1992;943-946.
95. Safhill R., Margison G.P., O'Connor P.J. Mechanisms of carcinogenesis induced by alkylating agents. Biochim. Biophys. Acta. 823:1985;111-145.
96. 2,3-ethenoguanine in livers of control and vinyl fluoride exposed B6C3F1 mice. Int. Toxicologist. 7:1995;. S-P-21.
97. Shields P.G. Pharmacogenetics: detecting sensitive populations. Environ. Health Perspect. 102:(Suppl. 11):1994;81-87.
98. Singer B. O-Alkyl pyrimidines in mutagenesis and carcinogenesis: occurrence and significance. Cancer Res. 46:1986;4879-4885.
99. Singer B., Essigmann J.M. Site-specific mutagenesis: retrospective and prospective. Carcinogenesis. 12:1991;949-955.
100. Singer B., Grunberger D. Molecular Biology of Mutagens and Carcinogens. 1983;Plenum Press, New York.
101. 4-methyldeoxythymidine using polymerases of varying fidelity. Carcinogenesis. 5:1984;1165-1171.
102. 2,3-ethenoguanosine , is a highly efficient mutagen in transcription. Carcinogenesis. 8:1987;745-747.
103. 2,3-etheno-deoxyguanosine , using a site-directed kinetic assay. Carcinogenesis. 12:1991;745-747.
104. Slaga T.J. Interspecies comparisons of tissue DNA damage, repair, fixation and replication. Environ. Health Perspect. 77:1988;73-82.
105. 6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA): implications for the mechanisms of NDMA hepatocarcinogenesis. Carcinogenesis. 16:1995;2381-2387.
106. 6-ethenoadenosine or 3,N4-ethenocytidine in polyribonucleotides. Nucleic Acids Res. 9:1981;365-373.
107. 01 study). J. Environ. Pathol. Toxicol. 3:1980;1-246.
108. Stowers S.J., Wiseman R.W., Ward J.M., Miller E.C., Miller J.A., Anderson M.W., Eva A. Detection of activated proto-oncogenes in N-nitrosodiethylamine induced liver tumors: a comparison between B6C3F1 mice and Fischer 344 rats. Carcinogenesis. 9:1988;271-276.
109. Strickland P.T., Routledge M.N., Dipple A. Methodologies for measuring carcinogen adducts in humans. Cancer Epidemiol. Biomarkers Prev. 2:1993;607-619.
110. Swenberg J.A., Barrow C.S., Boreiko C.J., d'A Heck H., Levine R.J., Morgan K.T., Starr T.B. Nonlinear biological responses to formaldehyde and their implications for carcinogenic risk assessment. Carcinogenesis. 4:1983;945-952.
111. 6-alkylguanine DNA repair activity during continuous exposure to carcinogen. Proc. Natl. Acad. Sci. USA. 79:1982;5499-5502.
112. 6-ethyldeoxyguanosine , accumulates in hepatocyte DNA of rats exposed continuously to diethylnitrosamine. Proc. Natl. Acad. Sci. USA. 81:1984;1692-1695.
113. Swenberg J.A., Fedtke N., Fennell T.R., Walker V.E. Relationships between carcinogen exposure, DNA adducts and carcinogenesis. Clayson D.B., Munro I.C., Shubik P., Swenberg J.A. Progress in Predictive Toxicology. 1990;161-184 Elsevier, Amsterdam.
114. Swenberg J.A., La D.K., Scheller N.A., Wu K.Y. Dose-response relationships for carcinogens. Toxicol. Lett. 82-83:1995;751-756.
115. Swenson D.H. Significance of electrophilic reactivity and especially DNA alkylation in carcinogenesis and mutagenesis. Hayes A.W., Schnell R.C., Miya T.S. Developments in the Science and Practice of Toxicology. 1983;247-254 Elsevier, Amsterdam.
116. Tang D., Santella R.M., Blackwood A.M., Young T.L., Mayer J., Jaretzki A., Grantham S., Tsai W.Y., Perera F.P. A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol. Biomarkers Prev. 4:1995;341-346.
117. Vainio H., Magee P.N., McGregor D.B., McMichael A.J. Mechanisms of Carcinogenesis in Risk Identification. IARC Scientific Publications No. 116. 1992;9-54 IARC, Lyon.
118. van Schooten F.J., Hillebrand M.J.X., van Leeuwen F.E., van Zandwijk N., Jansen H.M., den Engelse L., Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. Carcinogenesis. 13:1992;987-993.
119. Wellemans J., Cerny R.L., Gross M.L. Tandem mass spectrometry for the determination of deoxyribonucleic acid damage by polycyclic aromatic hydrocarbons. Analyst. 119:1994;497-503.
120. Weston A., Rowe M., Poirier M., Trivers G., Vahakangas K., Newman M., Haugen A., Manchester D., Mann D., Harris C. The application of immunoassays and fluorometry to the detection of polycyclic hydrocarbon-macromolecular adducts and anti-adduct antibodies in humans. Int. Arch. Occup. Environ. Health. 60:1988;157-162.
121. Wu K.Y., Scheller N., Cho M., Ranasinghe A., Upton P., Walker V.E., Swenberg J.A. Molecular dosimetry of hydroxyethyl adducts in DNA and hemoglobin following exposure of rats to ethylene and low doses of ethylene oxide. Int. Toxicologist. 7:1995;. 6-P-6.
122. You M., Wang Y., Lineen A.M., Gunning W.T., Stoner G.D., Anderson M.W. Mutagenesis of the K-ras protooncogene in mouse lung tumors induced by N-ethyl-N-nitrosourea or N-nitrosodiethylamine . Carcinogenesis. 13:1992;1583-1586.
123. Zaidi N.H., O'Conner P.J., Butler W.H. N-Methyl-N′-nitro-N-nitrosoguanidine-induced carcinogenesis: differential pattern of upper gastrointestinal tract tumours in Wistar rats after single or chronic doses. Carcinogenesis. 14:1993;1561-1567.